Hydralazine Hydrochloride
Product Images NDC 55289-133

2 FDA label images from Pd-rx Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 55289-133). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (4b54be21 F54e 41f0 B799 0561c30e8d51 01)

Image (4b54be21 F54e 41f0 B799 0561c30e8d51 01)
Chemical structure of hydralazine hydrochloride, showing two fused aromatic rings with attached hydrazine and nitrogen groups, along with the chemical formula C8H8N4 ยท HCl.*
FDA Label Image

55289133 Label (55289133)

55289133 Label (55289133)
HYDRALAZINE HCL USP 25 MG 60 TABLETS label from PD-Rx Pharmaceuticals, Inc. The label includes dosage strength, tablet count, NDC 55289-133-60, and instructions space for tablet intake. The label features a green and white color scheme with manufacturer details and safety warnings, including a dosage and storage notice and a caution to keep out of children's reach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.